Site icon Nasodren

A GA2LEN study (I part)

Chronic rhinosinusitis in Europe an underestimated disease.

Chronic Rhinosinusitis (CRS) is a common health problem, with significant medical cost and impact on general health. Even so, prevalence figures for Europe are unavailable. In this study, conducted by the GA2LEN network of excellence, the EP3OS diagnostic criteria are applied to estimate the prevalence of CRS in Europe.

Key messages from this study

Study method: Questionnaire was sent to a random sample of adults (15-75 years). Definition of Chronic Rhinosinusitis (CRS) based in EP3OS diagnostic criteria: the presence of more than two of the symptoms: (i) nasal blockage, (ii) nasal discharge, (iii) facial pain/pressure or (iv) reduction in sense of smell, for >12 weeks in the past year – with at least one symptom being nasal blockage or discharge.
Patients: 57.128 questionnaires returned presenting information from 19 centers in 12 countries.

D. Hastan, W. J. Fokkens, C. Bachert, R. B. Newson, J. Bislimovska, A. Bockelbrink, P. J. Bousquet, G. Brozek, A. Bruno, S. E. Dahlén, B. Forsberg, M. Gunnbjörnsdóttir, L. Kasper, U. Krämer, M. L. Kowalski, B. Lange, B. Lundbäck, E. Salagean, A. Todo-Bom, P. Tomassen, E. Toskala, C. M. van Drunen, J. Bousquet, T. Zuberbier, D. Jarvis & P. Burney
Allergy 2011; 66: 1216–1223.

Exit mobile version